摘要:
A process is provided for preparing a substituted 2,3-dihydrobenzofuran of the general formula ##STR1## in which R.sub.a is hydrogen, halogen, alkyl, straight or branched having from 1 to 4 carbon atoms, aryl, alkaryl, --OH, --OR.sub.3, --N(R.sub.d).sub.2, where R.sub.3 and R.sub.d are alkyl, straight or branched having from 1 to 4 carbon atoms; R.sub.b is alkyl, straight or branched, having from 1 to 6 carbon atoms, aryl, alkaryl; and R.sub.c is hydrogen or the same as R.sub.b, by the rearrangement of a 1,1-bis(2-hydroxybenzene) alkyl and/or aryl-ethane, in the presence of catalytic amounts of a mineral acid or organic acid such as phosphoric, sulfuric or p-toluenesulfonic, at elevated temperatures from 180.degree. to 250.degree. C., and withdrawing the resulting products from the reaction mixture as they are formed. The starting 1,1-bis(2-hydroxybenzene) alkyl and/or aryl-ethane compounds may be obtained by the catalyzed reaction of a substituted biphenol with an aldehyde. The substituted 2,3-dihydrobenzofurans are useful in the manufacture of pesticides.
摘要:
Solid polymeric stabilizer compound containing the hydroxybenzophenone function, having the general formula (I): ##STR1## wherein: m=from 0.01 to 0.99 (preferably from 0.1 to 0.6);l=from 0.99 to 0.01 (preferably from 0.9 to 0.4):m+l=1;R=H, --OH, --OR" (R"+(C.sub.1 -C.sub.20)-alkyl; aryl, alkylaryl cycloalkyl). halogen, (C.sub.1 -C.sub.20)-alkyl, cycloalkyl;R'=H, (C.sub.1 -C.sub.20)-alkyl, cycloalkyl.Also the process for preparing said solid polymeric stabilizers and the stabilized polymeric compositions comprising at least an organic polymer and a stabilizing amount of said solid polymeric stabilizers are disclosed.
摘要:
The invention provides a method of treating viral haemorrhagic fevers, such as that caused by Dengue virus, which comprises administering a composition comprising a pharmaceutically active amount of a matrix metalloproteinase inhibitor.
摘要:
A sensitive and accurate tissue culture system and kit for detecting subtle changes in immune function is provided. The system is based on the comparison of IL-2 production by T helper cells in response to recall antigens including influenza A virus, tatanus toxoid, alloantigens, mouse xenogeneic antigens and the like or combinations thereof. Different stages of immune dysfunction can be differentiated and organ graft rejection can be predicted by the method of the present invention.
摘要:
The invention discloses a catalyst on the basis of silicon and titanium having the form of microspheres and constituted by oligomeric silica and by titanium-silicalite crystals having an oligomeric silica/titanium-silicalite molar ratio comprised within the range of from 0.05 to 0.11, wherein the crystals of titanium-silicalite are encaged by means of Si-O-Si bridges.
摘要:
An inflammatory process is suggested to be involved in the pathogenesis of Alzheimer's disease (AD), a neurodegenerative disorder characterized by the presence of neuritic plaques within the cerebral cortex that are mainly composed of a small insoluble protein of 40-42 aminoacids (amyloid protein). Amyloid-specific Interleukin-10 (IL-10) generation is found to be selectively and significantly reduced in AD patients (p=0.023). The genotype associated with high IL-10 production is extremely infrequent in AD individuals (2% vs. 28%). The presence of low/intermediate-IL-10-producing genotypes (GCC/ATA; ATA/ATA) was associated with an earlier age at disease onset and (ACC/ACC; ACC/ATA) with an accelerated rate of disease progression/severity and with amyloid-specific impairment of IL-10 production. This relationship is independent of ApoE gene polymorphism. These results support the use of anti-inflammatory compounds in the therapy of this disease.
摘要:
The invention relates to the use of IL-22 alone or in combination as biomarker of resistance to infections in humans when added to of one or several agonists of the formyl peptide receptors (FPR) receptors family and formyl peptide receptors-like 1 (FPRL 1). Said biomarker is useful in diagnostics, prophylaxis and therapeutics.
摘要:
The invention relates to the therapeutic use of a second generation immunomodulatory oligonucleotide in combination with HIV-1 antigen or immunogen to enhance the ability to reduce the risk HIV infection and to control the progression of HIV infection to prevent AIDS Related Complex (ARC) and AIDS.
摘要:
A compound having catalytic properties which is a .sigma. or .pi. organic complex of a transition metal represented by the general formula: M (A).sub.n (L-C) (L).sub.m, wherein M is Ir or Re; L is a member of the group consisting of alkyl and aryl phosphines; (L-C) is (a) an alkyl or aryl phosphine ligand wherein a C-H bond is reacted with the central M atom to which the ligand is coordinated, and a metal-carbon bond is formed, or (b) a .pi.-allyl radical; A is a linear monoolefin having from 2 to 5 carbon atoms or a cyclic monoolefin having from 6 to 8 carbon atoms; n is a number in the range of 0 to 2 and is always zero when L-C is a .pi.-allyl radical; and m is a number from 1 to 3 which satisfies the valence of M, is prepared by reacting a hydride complex represented by the general formula: MHLn.sub.1 wherein M and L have the meaning given above, x is in the range from 5 to 7 and n.sub.1 is a number from 2 to 3 which satisfies the valence of M, with a linear monoolefin having from 2 to 5 carbon atoms or a cyclic monoolefin having from 6 to 8 carbon atoms.